Chowdhury Ujjwal K, Malik Vishwas, Yadav Rakesh, Seth Sandeep, Ramakrishnan Lakshmy, Kalaivani Mani, Reddy Srikrishna M, Subramaniam Ganapathy K, Govindappa Raghu, Kakani Madhava
Department of Cardiothoracic and Vascular Surgery, All India Institute of Medical Sciences, New Delhi, India.
J Thorac Cardiovasc Surg. 2008 May;135(5):1110-9, 1119.e1-10. doi: 10.1016/j.jtcvs.2007.12.029.
We sought to investigate the release pattern of different cardiac biomarkers (high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin) and to establish the diagnostic discrimination limits of each marker protein to evaluate perioperative myocardial injury in patients undergoing coronary artery bypass grafting with or without cardiopulmonary bypass.
Fifty patients were randomly assigned to on-pump or off-pump coronary artery bypass grafting. All cardiac biomarkers were measured in serial venous blood samples drawn before heparinization in both groups and after aortic unclamping at 1, 2, 4, 8, 24, 48, and 72 hours in the on-pump group. In the off-pump group samples were taken after the last distal anastomosis and at same time intervals as in the on-pump group.
The total amount of heart-type fatty acid-binding protein, cardiac troponin I, and high-sensitivity C-reactive protein released was significantly higher in the on-pump group than in the off-pump group. Receiver operating characteristic curve analysis of cardiac biomarkers indicated cardiac troponin I and heart-type fatty acid-binding protein as the superior diagnostic discriminators of myocardial injury, with an optimal cutoff value of greater than 0.92 ng/mL (area under the curve, 0.95 [95% CI, 0.88-1.00]; sensitivity, 92%; specificity, 92%; likelihood ratio [+], 11.50) and greater than 6.8 ng/mL (area under the curve, 0.94 [95% CI, 0.88-1.00]; sensitivity, 88%; specificity, 88%; likelihood ratio [+], 7.33), respectively. Logistic regression analysis revealed that patients with increased cardiac troponin I levels of greater than 0.92 ng/mL and heart-type fatty acid-binding protein levels of greater than 6.8 ng/mL were at 132.25 (95% confidence interval, 17.14-1020.49) times and 53.77 (95% confidence interval, 9.76-296.12) times higher risk of myocardial injury after on-pump coronary artery bypass grafting.
Off-pump coronary artery bypass grafting provides better myocardial protection than on-pump coronary artery bypass grafting. Cardiac troponin I and heart-type fatty acid-binding protein, but not high-sensitivity C-reactive protein, served as superior diagnostic discriminators of perioperative myocardial damage after on-pump coronary artery bypass grafting.
我们试图研究不同心脏生物标志物(高敏C反应蛋白、心肌肌钙蛋白I、心型脂肪酸结合蛋白、肌酸激酶同工酶MB和肌红蛋白)的释放模式,并确定每种标志物蛋白的诊断鉴别界限,以评估接受或未接受体外循环冠状动脉搭桥术患者的围手术期心肌损伤。
50例患者被随机分配接受体外循环或非体外循环冠状动脉搭桥术。两组均在肝素化前采集系列静脉血样检测所有心脏生物标志物,体外循环组在主动脉开放后1、2、4、8、24、48和72小时再次采集血样。非体外循环组在最后一个远端吻合术后采集血样,采样时间间隔与体外循环组相同。
体外循环组心型脂肪酸结合蛋白、心肌肌钙蛋白I和高敏C反应蛋白的总释放量显著高于非体外循环组。心脏生物标志物的受试者工作特征曲线分析表明,心肌肌钙蛋白I和心型脂肪酸结合蛋白是心肌损伤的更佳诊断鉴别指标,最佳临界值分别大于0.92 ng/mL(曲线下面积,0.95 [95%CI,0.88 - 1.00];敏感性,92%;特异性,92%;阳性似然比,11.50)和大于6.8 ng/mL(曲线下面积,0.94 [95%CI,0.88 - 1.00];敏感性,88%;特异性,88%;阳性似然比,7.33)。逻辑回归分析显示,体外循环冠状动脉搭桥术后,心肌肌钙蛋白I水平大于0.92 ng/mL且心型脂肪酸结合蛋白水平大于6.8 ng/mL的患者发生心肌损伤的风险分别高132.25倍(95%置信区间,17.14 - 1020.49)和53.77倍(95%置信区间,9.76 - 296.12)。
非体外循环冠状动脉搭桥术比体外循环冠状动脉搭桥术能提供更好的心肌保护。心肌肌钙蛋白I和心型脂肪酸结合蛋白,而非高敏C反应蛋白,是体外循环冠状动脉搭桥术后围手术期心肌损伤的更佳诊断鉴别指标。